
News|Podcasts|April 8, 2024
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Listen
0:00 / 0:00
Christopher Bunick, MD, PhD, delves into current data and guidelines to consider when creating custom treatment plans for patients with atopic dermatitis.
Advertisement
Christopher Bunick, MD, PhD, associate professor of dermatology at Yale School of Medicine in New Haven, Connecticut and Dermatology Times Editorial Advisory Board Member, decodes new atopic dermatitis treatment data and how that translates to personalized options for patients.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Grants Breakthrough Therapy Designation to Litifilimab for Cutaneous Lupus Erythematosus
2
Phase 2b Analysis Shows Consistent Vitiligo Repigmentation With Ritlecitinib
3
FAQtual Insights: Safe Approaches to Off Label Prescribing
4
Del Rosso's What's New in the Medicine Chest 2026: CHE, CSU, and Vitiligo
5










